With an experienced team comprised of around 200 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Reporting directly to the (CBO), this role acts as a key strategic partner to the Board and senior leadership, combining portfolio ownership, market intelligence, business case development, and cross‑functional project leadership. * Identification of new portfolio candidates for our development pipeline based on a variety of criteria including commercial attractiveness in our target markets, therapeutic area, competitive environment, development requirements * Development of portfolio prioritization frameworks aligned with strategic, financial, and ...
mehr